Cargando…
Perturbational Gene-Expression Signatures for Combinatorial Drug Discovery
Cancer is a complex disease that relies on both oncogenic mutations and non-mutated genes for survival, and therefore coined as oncogene and non-oncogene addictions. The need for more effective combination therapies to overcome drug resistance in oncology has been increasingly recognized, but the id...
Autores principales: | Huang, Chen-Tsung, Hsieh, Chiao-Hui, Chung, Yun-Hsien, Oyang, Yen-Jen, Huang, Hsuan-Cheng, Juan, Hsueh-Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525321/ https://www.ncbi.nlm.nih.gov/pubmed/31102995 http://dx.doi.org/10.1016/j.isci.2019.04.039 |
Ejemplares similares
-
A Large-Scale Gene Expression Intensity-Based Similarity Metric for Drug Repositioning
por: Huang, Chen-Tsung, et al.
Publicado: (2018) -
MicroRNA-mediated networks underlie immune response regulation in papillary thyroid carcinoma
por: Huang, Chen-Tsung, et al.
Publicado: (2014) -
Dynamic functional modules in co-expressed protein interaction networks of dilated cardiomyopathy
por: Lin, Chen-Ching, et al.
Publicado: (2010) -
Enhancement of the IFN-β-induced host signature informs repurposed drugs for COVID-19
por: Huang, Chen-Tsung, et al.
Publicado: (2020) -
A Single-Cell Network-Based Drug Repositioning Strategy for Post-COVID-19 Pulmonary Fibrosis
por: Li, Albert, et al.
Publicado: (2022)